OEM News, People

Medtronic Names Thierry Piéton as Chief Financial Officer

Interim CFO, Gary Corona, will continue in this role until March 3, after which he will become Senior Vice President of Corporate Finance.

Medtronic has appointed Thierry Piéton as the new Chief Financial Officer for the company, effective March 3, 2025. Gary Corona, who has been serving as interim CFO, will continue in this role until Piéton joins Medtronic in March. Then, Corona will become Senior Vice President of Corporate Finance and will remain on the Medtronic Executive Committee.

As CFO, Piéton will be responsible for leading the Medtronic global finance organization and key supporting functions, including Treasury, Controller, Tax, Internal Audit, Investor Relations, Corporate Strategy, and Business Development.

Piéton will report to Medtronic Chairman and Chief Executive Officer Geoff Martha and will join the Medtronic Executive Committee. Piéton joins Medtronic from Renault Group, where he has served as Chief Financial Officer since March 2022.

Under Piéton’s leadership, Renault achieved its highest-ever operating margins and improved free cash flow while executing portfolio management, including tuck-in acquisitions, divestitures, and funding development through innovative partnerships.

“Thierry is a strategic, creative, operationally focused, experienced CFO with a proven track record of delivering innovation-driven growth, margin improvement, and earnings power through strong financial leadership, which is directly aligned with our financial objectives,” said Geoff Martha, Medtronic chairman, and CEO. “We are confident he is the right choice at this important time for Medtronic and can’t wait to benefit from his expertise and leadership.”

Piéton’s prior experience includes healthcare and other highly regulated, operationally focused manufacturing companies, including Nissan Motor Co. Ltd, General Electric, GE Healthcare, and PricewaterhouseCoopers.

“I also want to recognize Gary Corona, who has served as interim CFO. Gary helped us deliver revenue growth and EPS that exceeded expectations in our first and second quarters and has provided strong leadership of our Finance function over the last six months. He will help ensure a smooth and successful transition, and I look forward to continuing to work with him in his new role leading several key Corporate finance functions,” said Martha.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters